Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
23
BKYI Quote, Financials, Valuation and Earnings
Last price:
$0.62
Seasonality move
:
8.55%
Day range:
$0.61 - $0.63
52-week range:
$0.61 - $3.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.49x
P/B ratio:
1.11x
Volume:
112.3K
Avg. volume:
1.7M
1-year change:
-38.8%
Market cap:
$6.7M
Revenue:
$6.9M
EPS (TTM):
-$1.02
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BKYI
BIO-key International, Inc.
|
$1.8M | -$0.12 | -16.08% | -69.31% | $2.00 |
|
CIX
CompX International, Inc.
|
-- | -- | -- | -- | -- |
|
IVDA
Iveda Solutions, Inc.
|
$2.5M | -$0.40 | 186.45% | -60.98% | -- |
|
KSCP
Knightscope, Inc.
|
$2.6M | -$0.80 | 0.05% | -79.48% | $15.00 |
|
NSSC
Napco Security Technologies, Inc.
|
$46.9M | $0.30 | 11.37% | 8.93% | $48.83 |
|
VRME
VerifyMe, Inc.
|
$4.7M | -$0.03 | -55.01% | -86.88% | $1.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BKYI
BIO-key International, Inc.
|
$0.62 | $2.00 | $6.7M | -- | $0.00 | 0% | 0.49x |
|
CIX
CompX International, Inc.
|
$22.93 | -- | $282.6M | 14.62x | $0.30 | 5.23% | 1.78x |
|
IVDA
Iveda Solutions, Inc.
|
$0.86 | -- | $5.1M | -- | $0.00 | 0% | 0.39x |
|
KSCP
Knightscope, Inc.
|
$3.87 | $15.00 | $44.5M | -- | $0.00 | 0% | 2.01x |
|
NSSC
Napco Security Technologies, Inc.
|
$41.94 | $48.83 | $1.5B | 34.15x | $0.14 | 1.3% | 8.12x |
|
VRME
VerifyMe, Inc.
|
$0.67 | $1.25 | $8.4M | -- | $0.00 | 0% | 0.37x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BKYI
BIO-key International, Inc.
|
19.49% | -1.219 | 27.8% | 1.14x |
|
CIX
CompX International, Inc.
|
-- | 0.047 | -- | 4.23x |
|
IVDA
Iveda Solutions, Inc.
|
16.95% | -5.201 | 12.88% | 2.95x |
|
KSCP
Knightscope, Inc.
|
21.93% | 3.537 | 12.59% | 3.22x |
|
NSSC
Napco Security Technologies, Inc.
|
2.92% | 2.992 | 0.67% | 5.56x |
|
VRME
VerifyMe, Inc.
|
6.98% | 1.034 | 7.66% | 3.54x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BKYI
BIO-key International, Inc.
|
$1.2M | -$892.2K | -70.08% | -91.16% | -57.57% | -$1.1M |
|
CIX
CompX International, Inc.
|
$11M | $4.8M | 13.3% | 13.3% | 11.92% | $5.3M |
|
IVDA
Iveda Solutions, Inc.
|
$517.3K | -$214.3K | -84.84% | -112.18% | -12.97% | -$315.8K |
|
KSCP
Knightscope, Inc.
|
-$1.7M | -$9.5M | -124.47% | -174.46% | -303.67% | -$8.6M |
|
NSSC
Napco Security Technologies, Inc.
|
$27.8M | $13.6M | 25.05% | 25.83% | 27.75% | $11.4M |
|
VRME
VerifyMe, Inc.
|
$1.8M | $418K | -34.76% | -38.89% | 8.31% | $9K |
BIO-key International, Inc. vs. Competitors
-
Which has Higher Returns BKYI or CIX?
CompX International, Inc. has a net margin of -62.26% compared to BIO-key International, Inc.'s net margin of 10.57%. BIO-key International, Inc.'s return on equity of -91.16% beat CompX International, Inc.'s return on equity of 13.3%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International, Inc.76.9% -$0.15 $7.5M CIXCompX International, Inc.27.61% $0.34 $137.7M -
What do Analysts Say About BKYI or CIX?
BIO-key International, Inc. has a consensus price target of $2.00, signalling upside risk potential of 220%. On the other hand CompX International, Inc. has an analysts' consensus of -- which suggests that it could grow by 15.12%. Given that BIO-key International, Inc. has higher upside potential than CompX International, Inc., analysts believe BIO-key International, Inc. is more attractive than CompX International, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International, Inc.0 0 0 CIXCompX International, Inc.0 0 0 -
Is BKYI or CIX More Risky?
BIO-key International, Inc. has a beta of 0.355, which suggesting that the stock is 64.505% less volatile than S&P 500. In comparison CompX International, Inc. has a beta of 1.060, suggesting its more volatile than the S&P 500 by 6.022%.
-
Which is a Better Dividend Stock BKYI or CIX?
BIO-key International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CompX International, Inc. offers a yield of 5.23% to investors and pays a quarterly dividend of $0.30 per share. BIO-key International, Inc. pays -- of its earnings as a dividend. CompX International, Inc. pays out 89.11% of its earnings as a dividend. CompX International, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BKYI or CIX?
BIO-key International, Inc. quarterly revenues are $1.5M, which are smaller than CompX International, Inc. quarterly revenues of $40M. BIO-key International, Inc.'s net income of -$964.8K is lower than CompX International, Inc.'s net income of $4.2M. Notably, BIO-key International, Inc.'s price-to-earnings ratio is -- while CompX International, Inc.'s PE ratio is 14.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International, Inc. is 0.49x versus 1.78x for CompX International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International, Inc.0.49x -- $1.5M -$964.8K CIXCompX International, Inc.1.78x 14.62x $40M $4.2M
-
Which has Higher Returns BKYI or IVDA?
Iveda Solutions, Inc. has a net margin of -62.26% compared to BIO-key International, Inc.'s net margin of -13.4%. BIO-key International, Inc.'s return on equity of -91.16% beat Iveda Solutions, Inc.'s return on equity of -112.18%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International, Inc.76.9% -$0.15 $7.5M IVDAIveda Solutions, Inc.31.32% -$0.07 $4.5M -
What do Analysts Say About BKYI or IVDA?
BIO-key International, Inc. has a consensus price target of $2.00, signalling upside risk potential of 220%. On the other hand Iveda Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 829.69%. Given that Iveda Solutions, Inc. has higher upside potential than BIO-key International, Inc., analysts believe Iveda Solutions, Inc. is more attractive than BIO-key International, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International, Inc.0 0 0 IVDAIveda Solutions, Inc.0 0 0 -
Is BKYI or IVDA More Risky?
BIO-key International, Inc. has a beta of 0.355, which suggesting that the stock is 64.505% less volatile than S&P 500. In comparison Iveda Solutions, Inc. has a beta of 0.845, suggesting its less volatile than the S&P 500 by 15.456%.
-
Which is a Better Dividend Stock BKYI or IVDA?
BIO-key International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Iveda Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International, Inc. pays -- of its earnings as a dividend. Iveda Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKYI or IVDA?
BIO-key International, Inc. quarterly revenues are $1.5M, which are smaller than Iveda Solutions, Inc. quarterly revenues of $1.7M. BIO-key International, Inc.'s net income of -$964.8K is lower than Iveda Solutions, Inc.'s net income of -$221.3K. Notably, BIO-key International, Inc.'s price-to-earnings ratio is -- while Iveda Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International, Inc. is 0.49x versus 0.39x for Iveda Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International, Inc.0.49x -- $1.5M -$964.8K IVDAIveda Solutions, Inc.0.39x -- $1.7M -$221.3K
-
Which has Higher Returns BKYI or KSCP?
Knightscope, Inc. has a net margin of -62.26% compared to BIO-key International, Inc.'s net margin of -304.66%. BIO-key International, Inc.'s return on equity of -91.16% beat Knightscope, Inc.'s return on equity of -174.46%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International, Inc.76.9% -$0.15 $7.5M KSCPKnightscope, Inc.-53.34% -$0.98 $34.5M -
What do Analysts Say About BKYI or KSCP?
BIO-key International, Inc. has a consensus price target of $2.00, signalling upside risk potential of 220%. On the other hand Knightscope, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 287.6%. Given that Knightscope, Inc. has higher upside potential than BIO-key International, Inc., analysts believe Knightscope, Inc. is more attractive than BIO-key International, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International, Inc.0 0 0 KSCPKnightscope, Inc.3 0 0 -
Is BKYI or KSCP More Risky?
BIO-key International, Inc. has a beta of 0.355, which suggesting that the stock is 64.505% less volatile than S&P 500. In comparison Knightscope, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BKYI or KSCP?
BIO-key International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Knightscope, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International, Inc. pays -- of its earnings as a dividend. Knightscope, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKYI or KSCP?
BIO-key International, Inc. quarterly revenues are $1.5M, which are smaller than Knightscope, Inc. quarterly revenues of $3.1M. BIO-key International, Inc.'s net income of -$964.8K is higher than Knightscope, Inc.'s net income of -$9.5M. Notably, BIO-key International, Inc.'s price-to-earnings ratio is -- while Knightscope, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International, Inc. is 0.49x versus 2.01x for Knightscope, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International, Inc.0.49x -- $1.5M -$964.8K KSCPKnightscope, Inc.2.01x -- $3.1M -$9.5M
-
Which has Higher Returns BKYI or NSSC?
Napco Security Technologies, Inc. has a net margin of -62.26% compared to BIO-key International, Inc.'s net margin of 24.74%. BIO-key International, Inc.'s return on equity of -91.16% beat Napco Security Technologies, Inc.'s return on equity of 25.83%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International, Inc.76.9% -$0.15 $7.5M NSSCNapco Security Technologies, Inc.56.63% $0.34 $181.4M -
What do Analysts Say About BKYI or NSSC?
BIO-key International, Inc. has a consensus price target of $2.00, signalling upside risk potential of 220%. On the other hand Napco Security Technologies, Inc. has an analysts' consensus of $48.83 which suggests that it could grow by 16.44%. Given that BIO-key International, Inc. has higher upside potential than Napco Security Technologies, Inc., analysts believe BIO-key International, Inc. is more attractive than Napco Security Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International, Inc.0 0 0 NSSCNapco Security Technologies, Inc.5 0 0 -
Is BKYI or NSSC More Risky?
BIO-key International, Inc. has a beta of 0.355, which suggesting that the stock is 64.505% less volatile than S&P 500. In comparison Napco Security Technologies, Inc. has a beta of 1.473, suggesting its more volatile than the S&P 500 by 47.323%.
-
Which is a Better Dividend Stock BKYI or NSSC?
BIO-key International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Napco Security Technologies, Inc. offers a yield of 1.3% to investors and pays a quarterly dividend of $0.14 per share. BIO-key International, Inc. pays -- of its earnings as a dividend. Napco Security Technologies, Inc. pays out 43.31% of its earnings as a dividend. Napco Security Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BKYI or NSSC?
BIO-key International, Inc. quarterly revenues are $1.5M, which are smaller than Napco Security Technologies, Inc. quarterly revenues of $49.2M. BIO-key International, Inc.'s net income of -$964.8K is lower than Napco Security Technologies, Inc.'s net income of $12.2M. Notably, BIO-key International, Inc.'s price-to-earnings ratio is -- while Napco Security Technologies, Inc.'s PE ratio is 34.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International, Inc. is 0.49x versus 8.12x for Napco Security Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International, Inc.0.49x -- $1.5M -$964.8K NSSCNapco Security Technologies, Inc.8.12x 34.15x $49.2M $12.2M
-
Which has Higher Returns BKYI or VRME?
VerifyMe, Inc. has a net margin of -62.26% compared to BIO-key International, Inc.'s net margin of -66.68%. BIO-key International, Inc.'s return on equity of -91.16% beat VerifyMe, Inc.'s return on equity of -38.89%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International, Inc.76.9% -$0.15 $7.5M VRMEVerifyMe, Inc.35.61% -$0.26 $11.9M -
What do Analysts Say About BKYI or VRME?
BIO-key International, Inc. has a consensus price target of $2.00, signalling upside risk potential of 220%. On the other hand VerifyMe, Inc. has an analysts' consensus of $1.25 which suggests that it could grow by 85.98%. Given that BIO-key International, Inc. has higher upside potential than VerifyMe, Inc., analysts believe BIO-key International, Inc. is more attractive than VerifyMe, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International, Inc.0 0 0 VRMEVerifyMe, Inc.0 0 0 -
Is BKYI or VRME More Risky?
BIO-key International, Inc. has a beta of 0.355, which suggesting that the stock is 64.505% less volatile than S&P 500. In comparison VerifyMe, Inc. has a beta of 0.294, suggesting its less volatile than the S&P 500 by 70.591%.
-
Which is a Better Dividend Stock BKYI or VRME?
BIO-key International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VerifyMe, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International, Inc. pays -- of its earnings as a dividend. VerifyMe, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKYI or VRME?
BIO-key International, Inc. quarterly revenues are $1.5M, which are smaller than VerifyMe, Inc. quarterly revenues of $5M. BIO-key International, Inc.'s net income of -$964.8K is higher than VerifyMe, Inc.'s net income of -$3.4M. Notably, BIO-key International, Inc.'s price-to-earnings ratio is -- while VerifyMe, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International, Inc. is 0.49x versus 0.37x for VerifyMe, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International, Inc.0.49x -- $1.5M -$964.8K VRMEVerifyMe, Inc.0.37x -- $5M -$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
56
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
